These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6306919)

  • 41. Attachment of neutralizing antibodies stabilizes the capsid of poliovirus against uncoating.
    Wetz K
    Virology; 1993 Feb; 192(2):465-72. PubMed ID: 8380661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunocytochemical localization of capsid-related particles in subcellular fractions of poliovirus-infected cells.
    Pfister T; Pasamontes L; Troxler M; Egger D; Bienz K
    Virology; 1992 Jun; 188(2):676-84. PubMed ID: 1316678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigenic N to H conversion of poliovirus by a monoclonal antibody at low ionic strength.
    Delaet I; Vrijsen R; Boeyé A
    Virology; 1992 May; 188(1):93-101. PubMed ID: 1314469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [On the antigen-antibody reaction of in vitro neutralization of poliomyelitis virus].
    Hässelbarth A; Drees O
    Zentralbl Bakteriol Orig; 1965 Dec; 198(1):230-6. PubMed ID: 4290199
    [No Abstract]   [Full Text] [Related]  

  • 45. Antibodies to poliovirus detected by immunoradiometric assay with a monoclonal antibody.
    Spitz M; Fossati CA; Schild GC; Spitz L; Brasher M
    J Virol Methods; 1982 Oct; 5(2):101-11. PubMed ID: 6296172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus.
    Pasamontes L; Egger D; Bienz K
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2415-22. PubMed ID: 2431100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hybridoma antibodies to poliovirus N and H antigen.
    Brioen P; Sijens RJ; Vrijsen R; Rombaut B; Thomas AA; Jackers A; Boeyé A
    Arch Virol; 1982; 74(4):325-30. PubMed ID: 6187316
    [No Abstract]   [Full Text] [Related]  

  • 48. Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein.
    Emini EA; Dorner AJ; Dorner LF; Jameson BA; Wimmer E
    Virology; 1983 Jan; 124(1):144-51. PubMed ID: 6186073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of specificity of antibodies contained in antiserum against poliovirus with mutants resistant to inhibitors in equine serum.
    Urasawa S; Urasawa T; Kanamitsu M
    J Immunol; 1974 Aug; 113(2):537-42. PubMed ID: 4367633
    [No Abstract]   [Full Text] [Related]  

  • 50. Examination of virus-gamma-M antibody complexes by electron microscopy. I. Configuration of gamma-M antibodies and mode of attachment to antigen.
    Svehag SE; Bloth B
    Virology; 1967 Apr; 31(4):676-87. PubMed ID: 4164533
    [No Abstract]   [Full Text] [Related]  

  • 51. Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus.
    Yuste E; Johnson W; Pavlakis GN; Desrosiers RC
    J Virol; 2005 Oct; 79(19):12455-63. PubMed ID: 16160173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the nonneutralizable fraction of poliovirus.
    Lewenton-Kriss S; Mandel B
    Virology; 1972 Jun; 48(3):666-78. PubMed ID: 4337990
    [No Abstract]   [Full Text] [Related]  

  • 53. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.
    Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P
    J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electron microscopic examination of the reactivity of three kinds of neutralizing antibodies with H particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    Microbiol Immunol; 1983; 27(7):645-8. PubMed ID: 6195513
    [No Abstract]   [Full Text] [Related]  

  • 55. Monoclonal antibodies that disrupt poliovirus only at fever temperatures.
    Delaet I; Boeyé A
    J Virol; 1993 Sep; 67(9):5299-302. PubMed ID: 8394450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of polioviral proteins of the P2 genomic region with the viral replication complex and virus-induced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography.
    Bienz K; Egger D; Pasamontes L
    Virology; 1987 Sep; 160(1):220-6. PubMed ID: 2820130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A comparison of the diagnostic value of the virus neutralization reaction and of indirect immunoenzyme analysis using monoclonal antibodies for the intratype differentiation of vaccinal and virulent poliovirus strains].
    Nikolaienko IV
    Lik Sprava; 1998 May; (3):84-6. PubMed ID: 9695574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural studies of virus-antibody immune complexes (poliovirus type I): Characterization of the epitopes in 3D.
    Bannwarth L; Girerd-Chambaz Y; Arteni AA; Guigner JM; Lemains J; Ronzon F; Manin C; Vénien-Bryan C
    Mol Immunol; 2015 Feb; 63(2):279-86. PubMed ID: 25146483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine.
    Gary HE; Freeman C; Peñaranda S; Maher K; Anderson L; Pallansch MA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S264-7. PubMed ID: 9203727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new antigenic site of poliovirus recognized by an intertypic cross-neutralizing monoclonal antibody.
    Uhlig J; Wiegers K; Dernick R
    Virology; 1990 Oct; 178(2):606-10. PubMed ID: 2171198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.